Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
14.38
-0.05 (-0.35%)
At close: Jul 24, 2025, 4:00 PM
14.63
+0.25 (1.74%)
After-hours: Jul 24, 2025, 4:29 PM EDT
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $584.05 million as of July 24, 2025. Its market cap has decreased by -61.17% in one year.
Market Cap
584.05M
Enterprise Value
-118.08M
1-Year Change
-61.17%
Ranking
Category
Stock Price
$14.38
Market Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has increased from $385.32M to $584.05M, an increase of 51.57%. That is a compound annual growth rate of 8.17%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 697.04B |
| Johnson & Johnson | 404.05B |
| AbbVie | 330.51B |
| Novo Nordisk | 295.77B |
| UnitedHealth Group | 258.65B |
| Novartis AG | 224.80B |
| Abbott Laboratories | 218.75B |
| AstraZeneca | 216.82B |